Charles A. Sanders, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $43.97 ($218K) on 2006-12-07, disclosed to the SEC on 2006-12-11.
Scheduled sale ($218k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.97 | 3,000 | $132K | 60.6% |
| 2 | $42.95 | 2,000 | $86K | 39.4% |
| Total | $43.56 avg | 5,000 | $218K | 100% |
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |